跳至主要内容
临床试验/IRCT201312212417N15
IRCT201312212417N15已完成3 期

Effect of pentoxifyllin on microalbominuria in patients with diabetic nephropathy

Vice Chancellor for Research, Isfahan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 90 years(—)
性别
All

入选标准

  • 1.Estimated glomerular filtration rate: higher than 60 mL/min/1.73 m2; 2.Blood pressure: less than 140/90 mmHg by using anti hypertensive drugs in the last six month 3.protein intake: less than 0.8gr/kg/d; 4.controlled blood glucose (glycosylated hemoglobin: less than 8%); 5.Spot urine albumin to creatinine ratio: less than 300 mg/g in 3 consecutive measurements during a 3 months screening period.
  • exclusion criteria: 1.Myocardial infarction; 2.Stroke; 3.Retinal hemorrhage in last 6 months; 4.abnormal liver function tests ; 5.Congestive heart failure (New York Heart Association class III or IV); 6.Obstructive uropathy 7.Active malignancy; 8.Patients who could not discontinue immunosuppressive or nonsteroidal anti inflammatory drugs; 9.Pregnant or breast feeding women 10. changes in anti-hypertensive drugs 11.other cause of proteinuria

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Isfahan University of Medical Sciences

相似试验